Greg Weaver
AeroLeads people directory · profile

Greg Weaver Email & Phone Number

Chief Financial Officer at Altimmune, Inc.
Location: Gaithersburg, Maryland, United States 12 work roles 2 schools
LinkedIn matched
✓ Verified Jun 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Financial Officer
Location
Gaithersburg, Maryland, United States
Company size

Who is Greg Weaver? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Greg Weaver is listed as Chief Financial Officer at Altimmune, Inc., a company with 44 employees, based in Gaithersburg, Maryland, United States. AeroLeads shows a matched LinkedIn profile for Greg Weaver.

Greg Weaver previously worked as CFO Consulting at Morningside Ventures and CFO at Cognito Therapeutics, Inc.. Greg Weaver holds Master Of Business Administration - Mba, Accounting And Finance from Boston College.

Company email context

Email format at Altimmune, Inc.

This section adds company-level context without repeating Greg Weaver's masked contact details.

Altimmune, Inc.

Review company-level records connected to Greg Weaver before choosing the right outreach path.

Profile bio

About Greg Weaver

30 year career in CFO executive roles across biotech, medtech, digital health, accounting and finance.

Current workplace

Greg Weaver's current company

Company context helps verify the profile and gives searchers a useful next step.

Altimmune, Inc.
Altimmune, Inc.
Chief Financial Officer
gaithersburg, maryland, united states
Website
Employees
44
AeroLeads page
12 roles · 27 years

Greg Weaver work experience

A career timeline built from the work history available for this profile.

Chief Financial Officer

Current

Gaithersburg, Maryland, United States

Nov 2024 - Present

Cfo Consulting

Morningside Ventures

MedTech CFO consulting services to Cognito, NeuroElectrics.

Jun 2024 - Nov 2024

Cfo

Led S-1 IPO readiness, built financial team, managed banking activities. Currently completing $60M C round and RIF restructuring. Focused on Alzheimer's ph3.

Sep 2023 - Jun 2024

Cfo

United States

Successful IPO for Berlin/NYC based mental health company. Led public company finance execution and built the team and public company infrastructure and street presence.Key Accomplishmentso Core team member responsible for $259 million Nasdaq IPO in June 2021, market cap $2.5Bo Managed complexities of platform structure with varied ownership of 15 mental.

Jun 2020 - Aug 2022

Cfo

Eloxx

Boston, Massachusetts, United States

Led rare disease start-up through a reverse merger/ US IPO in 2018 and built the finance function. Lead asset in cystic fibrosis phase 2 clinical trials.Key Accomplishmentso Led $100 million in two follow-on financings/ATMo Managed merger tail through many finance and legal challengeso Opened Boston HQ office, recruited accounting, finance and IR teams in.

Sep 2017 - Mar 2020

Cfo

Prometic

Montreal, Quebec, Canada

TSX/Nasdaq listed; led global financial ops and IR for this commercial resins and clinical stage plasma therapeutics company, Split time between Montreal, Cambridge UK and Boston offices. Company restructured into a newco, Liminal Biosciences following my departure.Key Accomplishmentso Raised $170 million with institutional investorso Led transition from.

2015 - 2017 ~2 yrs

Cfo

Fibrocell

Nasdaq autologous skin therapy Phase 2 clinical stage biotech.

2013 - 2014 ~1 yr

Cfo

Poniard

Nasdaq Phase 3 oncology trial missed primary endpoint; led to dissolution.

2009 - 2011 ~2 yrs

Cfo

Talyst

Seattle, Washington, United States

Pre-IPO MedTech hospital pharmacy automation company. S1 drafted, remained private.

2007 - 2008 ~1 yr

Cfo

Sirna

Nasdaq RNAi clinical focus, exit to Merck.

2006 - 2007 ~1 yr

Cfo

Nastech

Nasdaq nasal delivery with multiple phase 2 clinical programs/collaborations.

2002 - 2005 ~3 yrs

Cfo

San Antonio, Texas, United States

Nasdaq listed, FDA approval of Campath and Clorfarabine. Millennium strategic collaboration, exit to Genzyme in 2005.

1999 - 2002 ~3 yrs
Team & coworkers

Colleagues at Altimmune, Inc.

Other employees you can reach at altimmune.com. View company contacts for 44 employees →

2 education records

Greg Weaver education

Master Of Business Administration - Mba, Accounting And Finance

Bs, Accounting And Finance

Trinity University
FAQ

Frequently asked questions about Greg Weaver

Quick answers generated from the profile data available on this page.

What company does Greg Weaver work for?

Greg Weaver works for Altimmune, Inc..

What is Greg Weaver's role at Altimmune, Inc.?

Greg Weaver is listed as Chief Financial Officer at Altimmune, Inc..

Where is Greg Weaver based?

Greg Weaver is based in Gaithersburg, Maryland, United States while working with Altimmune, Inc..

What companies has Greg Weaver worked for?

Greg Weaver has worked for Altimmune, Inc., Morningside Ventures, Cognito Therapeutics, Inc., Atai Life Sciences, and Eloxx.

Who are Greg Weaver's colleagues at Altimmune, Inc.?

Greg Weaver's colleagues at Altimmune, Inc. include Koren Jarvis Anderson, Melissa Cates, Mha, Laura Gibbs, Linda Young, and Aklilu Meshesha, Cpa, Mba.

How can I contact Greg Weaver?

You can use AeroLeads to view verified contact signals for Greg Weaver at Altimmune, Inc., including work email, phone, and LinkedIn data when available.

What schools did Greg Weaver attend?

Greg Weaver holds Master Of Business Administration - Mba, Accounting And Finance from Boston College.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Greg Weaver you were looking for.

View similar profiles